3 min read
Adapting Human Connection in a Virtual World
How We Planned an International Meeting in a Pandemic
Looking back, 2020 has taught us all a few lessons we were not expecting to learn.
Home >
Blog
Blog | Veristat
Gain the latest insights and trends in clinical trials, patient recruitment, data analysis, adaptive design, regulatory submissions and approvals.
Sign Up Today
3 min read
Regulatory Guidance Monthly Review - November 2020
January 12, 2021
November 2020
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) that are pertinent to the governance of clinical trials and drug, biologic, or medical...
3 min read
Regulatory Guidance Monthly Review - October 2020
November 17, 2020
October 2020
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) that are pertinent to the governance of clinical trials and drug, biologic, or medical...
2 min read
Regulatory Guidance Monthly Review - September 2020
October 7, 2020
September 2020
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) that are pertinent to the governance of clinical trials and drug, biologic, or medical...
3 min read
Regulatory Guidance Monthly Review - August 2020
September 8, 2020
August 2020
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) that are pertinent to the governance of clinical trials and drug, biologic, or medical...
3 min read
Regulatory Guidance Monthly Review - July 2020
August 31, 2020
July 2020
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) that are pertinent to the governance of clinical trials and drug, biologic, or medical...
3 min read
Regulatory Guidance Monthly Review - June 2020
July 8, 2020
June 2020
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) that are pertinent to the governance of clinical trials and drug, biologic, or medical...
3 min read
Regulatory Guidance Monthly Review - May 2020
June 2, 2020
MAY 2020
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) that are pertinent to the governance of clinical trials and drug, biologic, or medical device...
3 min read
EMA Guidance on Management of Clinical Trials during COVID-19 Pandemic
May 14, 2020
Summary of Key Considerations Outlined in the Third Edition of the EMA Guidance
The European Medicines Agency (EMA) has now published its third version of the Guidance on the Management of Clinical Trials during the COVID-19 (Coronavirus) Pandemic....
3 min read
Clinical Trial Conduct During COVID-19 Pandemic Response
May 5, 2020
Key Lessons Learned during the First Month of the COVID-19 Pandemic Response
As we are well-rooted in the response phase of the COVID-19 pandemic, we have seen a flurry of sponsors looking through their pipelines to find either approved or...